AROA BIOSURGERY ORDINARY (ARX) Short Interest
AROA BIOSURGERY ORDINARY (ASX:ARX) had 0.00% of shares reported as short positions as of 16 July 2026, representing 921 shares. AROA BIOSURGERY ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Aroa Biosurgery
AROA Biosurgery Limited specializes in regenerative healing products for soft-tissue repair. It emphasizes the use of extracellular matrix (ECM) biomaterials in its offerings, giving it a niche position in the medical devices market. The company aims to improve healing outcomes and reduce healthcare costs, standing out through its innovative solutions and successful commercialization strategies.
Short position
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4ARX intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Aroa Biosurgery
Latest ARX news
All news- Long Shortz with Aroa Biosurgery: Symphony remains well positioned under CMS proposal
stockhead
- Aroa Biosurgery Reports Expiry and Lapse of Over 4 Million Securities Affecting Equity Structure
kalkine
- Notification of cessation of securities - ARX
asx
- Symphony - Outpatient Reimbursement Update
asx
- Aroa Biosurgery (ASX:ARX) in focus as reimbursement clarity approaches
kalkine
About
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss ARX
Start a research thread or post the first pulse update